Related Experiment Videos
2', 5' oligo (A) synthetase levels in interferon-sensitive or resistant breast cancer cells
1Theagenion Memorial Cancer Institute, Greece.
Microbiologica
|April 1, 1988
Abstract:
The levels of 2', 5' oligo (A) synthetase increase 15-fold when T47D cells are treated with human interferon or with interferon inducers. The results also show that interferon-treated T47D cells contain high levels of 2', 5' oligo (A) synthetase which upon incubation with ATP produces adenine oligonucleotides which are predominantly trimers. In contrast, MCF-7 and BT20 cells whether treated with interferon or not exhibit low 2', 5' oligo (A) synthetase activity.
Insights
Human interferon significantly boosts 2
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Interferons are crucial signaling proteins in the innate immune system.
- 2', 5'-Oligoadenylate synthetase (2-5 OAS) is an interferon-stimulated enzyme involved in antiviral pathways.
Purpose of the Study:
- To investigate the effect of human interferon on 2', 5'-OAS activity in different breast cancer cell lines.
- To characterize the products of 2', 5'-OAS in interferon-treated cells.
Main Methods:
- Treatment of T47D, MCF-7, and BT20 cells with human interferon or interferon inducers.
- Assay of 2', 5'-OAS enzyme activity.
- Incubation of enzyme with ATP to analyze oligonucleotide products.
Main Results:
- A 15-fold increase in 2', 5'-OAS levels was observed in T47D cells upon interferon treatment.
- Interferon-treated T47D cells produced predominantly trimeric adenine oligonucleotides from ATP.
- MCF-7 and BT20 cells showed low 2', 5'-OAS activity regardless of interferon treatment.
Conclusions:
- Human interferon potently induces 2', 5'-OAS in T47D breast cancer cells.
- The induced enzyme produces specific adenine oligonucleotide products.
- Differential regulation of 2', 5'-OAS exists across breast cancer cell lines.